Victory Capital Management Inc Evelo Biosciences, Inc. Transaction History

Victory Capital Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$3.53 - $6.12 $313,915 - $544,239	-88,928 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$3.21 - $7.06 $9,517 - $20,932	-2,965 Reduced 3.23%	88,928 $334,000
Q4 2019 Feb 06, 2020	SELL	$3.81 - $7.45 $742 - $1,452	-195 Reduced 0.21%	91,893 $373,000
Q4 2019 Feb 04, 2020	SELL	$3.81 - $7.45 $13,117 - $25,650	-3,443 Reduced 3.6%	92,088 $541,000
Q3 2019 Nov 12, 2019	BUY	$5.45 - $8.8 $171,740 - $277,305	31,512 Added 49.22%	95,531 $583,000

Q2 2019 Aug 15, 2019	SELL	$6.52 - $9.42 $152,248 - $219,966	-23,351 Reduced 26.73%	64,019 $575,000
Q1 2019 May 03, 2019	SELL	$7.5 - $15.31 $6,600 - $13,472	-880 Reduced 1.0%	87,370 $699,000
Q4 2018 Feb 05, 2019	SELL	$7.29 - $13.01 $11,153 - $19,905	-1,530 Reduced 1.7%	88,250 $1.15 Million
Q3 2018 Nov 01, 2018	SELL	$11.93 - $14.76 $58,099 - $71,881	-4,870 Reduced 5.15%	89,780 $1.09 Million
Q2 2018 Aug 02, 2018	BUY	$11.39 - $16.26 $1.08 Million - $1.54 Million	94,650 New	94,650 $1.12 Million

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.